We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas

This study is currently recruiting participants.
Verified July 2016 by David Piccioni, M.D., Ph.D, University of California, San Diego
Sponsor:
ClinicalTrials.gov Identifier:
NCT01140568
First Posted: June 9, 2010
Last Update Posted: July 11, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
Novartis
Information provided by (Responsible Party):
David Piccioni, M.D., Ph.D, University of California, San Diego
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2018
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)